Skip to main content
HairCited

Minoxidil için Kadın Tipi Saç Dökülmesi

A

67 çalışmaya (4 meta-analyses, 11 RCTs), toplam 28,815 katılımcıyla dayanmaktadır. 53/67 çalışma olumlu etkiler göstermektedir.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dminoxidil\u0026condition\u003Dfemale\u002Dpattern\u002Dhair\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Sonuç

Research strongly suggests that minoxidil may help women with female pattern hair loss regain hair density, supported by numerous high-quality clinical trials.

  • 67 studies including 11 RCTs and 4 meta-analyses specifically in women
  • 79% of studies report positive effects on hair growth
  • Low-dose oral minoxidil is emerging as a well-tolerated alternative to topical application
  • Combination with other ingredients like spironolactone may enhance results

Key Study Findings

Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None vs: None Outcome: None Etki: None None

Popülasyon: women with androgenetic alopecia (female pattern hair loss)

Other
Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern …
Dose: MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day vs: None Outcome: consensus recommendations for managing pattern hair loss Etki: None None

Popülasyon: hair transplant patients with male and female pattern hair loss (Delphi panel consensus)

review
Antiandrogen therapy for the treatment of female pattern hair loss: A clinical review of current …
Dose: varies by agent and study vs: Placebo Etki: variable; oral antiandrogens demonstrate some efficacy; topical antiandrogens possibly fewer systemi None
randomized controlled trial n=45 16 weeks Open-label
Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in …
Dose: Group A: topical finasteride 1% solution; Group B: topical spironolactone 5% solution; Group C: topi vs: Placebo Etki: Groups A and C showed significant improvement on Sinclair scale and trichoscopic hair density; Group None
Review
Male and female pattern hair loss.
Dose: None vs: Placebo Etki: None None

Key Statistics

111

Çalışmalar

37800

Katılımcılar

Positive

A

Derece

Referenced Papers

Australian prescriber 2025 2 atıf
Annals of dermatology 2025
SAGE open medical … 2024 3 atıf
Drugs 2023 221 atıf
Anais brasileiros de … 2023 29 atıf
Journal of cosmetic … 2023 3 atıf
The Journal of … 2022 170 atıf
Faculty reviews 2022 44 atıf
Journal of cosmetic … 2022 7 atıf
Journal of the … 2021 42 atıf
International journal of … 2020 58 atıf
Indian dermatology online … 2020 31 atıf
Australian journal of … 2018 8 atıf
JAMA dermatology 2017 121 atıf
The Cochrane database … 2016 18 atıf
World journal of … 2015 62 atıf
Seminars in cutaneous … 2015 20 atıf
Clinical obstetrics and … 2015 9 atıf
Current problems in … 2015 8 atıf
Skin therapy letter 2014 29 atıf
Dermatologic clinics 2013 78 atıf
International journal of … 2013 61 atıf
Indian journal of … 2013 16 atıf
International journal of … 2013
The Cochrane database … 2012 15 atıf
Skinmed 2012 5 atıf
Seminars in cutaneous … 2009 4 atıf
American family physician 2009
Journal of the … 2008 290 atıf
Clinical interventions in … 2007
Duodecim; laaketieteellinen aikakauskirja 2006
The British journal … 2005 205 atıf
The journal of … 2003 102 atıf
Clinical and experimental … 2002 61 atıf
Therapeutische Umschau. Revue … 2002 4 atıf

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

topical:
2-5% solution, twice daily

Üst sınır: 5% topical solution

Araştırmalarda İncelenen Dozajlar

Dozaj Süre Etki N
None -- Neutral --
MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day -- Positive --
varies by agent and study -- Positive --
None -- Positive --
Group A: topical finasteride 1% solution; Group B: topical spironolactone 5% solution; Group C: topi 16 weeks Positive 45
None -- Positive --
Spironolactone 100 mg once daily 24 weeks Positive 48
None -- Positive --

En iyi alım zamanı: Apply to dry scalp morning and evening, at least 4 hours before bed

Safety & Side Effects

Bildirilen Yan Etkiler

  • Scalp irritation and dryness
  • Initial shedding phase (first 2-8 weeks)
  • Unwanted facial hair growth (especially in women)
  • Dizziness or lightheadedness (rare with topical use)
  • Heart palpitations (rare, more common with oral form)

Bilinen Etkileşimler

  • Antihypertensive medications (additive blood pressure lowering)
  • Topical corticosteroids (may increase absorption)
  • Retinoids (tretinoin may enhance penetration and side effects)

Tolere edilebilir üst alım: 5% topical solution

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does Minoxidil help with Kadın Tipi Saç Dökülmesi?
Based on 111 studies with 37,800 participants, there is strong evidence from multiple clinical trials that Minoxidil may support Kadın Tipi Saç Dökülmesi management. Our evidence grade is A (Strong Evidence).
How much Minoxidil should I take for Kadın Tipi Saç Dökülmesi?
Studies have used various dosages. A commonly studied range is 2-5% solution, twice daily. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Minoxidil?
Reported side effects may include Scalp irritation and dryness, Initial shedding phase (first 2-8 weeks), Unwanted facial hair growth (especially in women), Dizziness or lightheadedness (rare with topical use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Minoxidil and Kadın Tipi Saç Dökülmesi?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 111 peer-reviewed studies with 37,800 total participants. The overall direction of effect is positive.

Related Evidence

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.